The following cleansing notice was lodged with ASX on November 25, 2021:
Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 19 November 2021 and 25 December 2021 the Company issued 20,255,128 fully paid ordinary shares (Shares) in the Company as the result of shareholders exercising their options in the Company.
Click to review the full announcement at ASX.
Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSense® HER2 Phase 2 Study Immediate Priority
Imagion Biosystems (ASX: IBX) (Company), is pleased to announce the Company has received $3 million of firm commitments through a highly successful capital raising. The
Open a copy of this presentation deck from our ASX announcement HERE. Video transcript: Mel: Good morning, everyone. Thank you for attending the investor presentation
We’re on a mission to make cancer more detectable.
Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.
Stay informed about our latest news and developments.
© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance